Related Experiment Video
Updated: May 25, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
Simulation optimization of PSA-threshold based prostate cancer screening policies.
Daniel J Underwood1, Jingyu Zhang, Brian T Denton
1Edward P. Fitts Department of Industrial & Systems Engineering, North Carolina State University, Raleigh, NC 27695, USA. daniel.underwood@ncsu.edu
This study introduces a simulation optimization method to enhance prostate-specific antigen (PSA) screening policies, aiming to maximize quality-adjusted life years (QALYs). The findings suggest more aggressive, shorter screening durations than current guidelines recommend.
Area of Science:
- Health economics
- Biostatistics
- Medical decision making
Background:
- Prostate-specific antigen (PSA) screening guidelines impact patient outcomes and healthcare costs.
- Optimizing screening policies is crucial for maximizing benefits while minimizing harms.
Purpose of the Study:
- To develop and evaluate a simulation optimization method for designing effective PSA screening policies.
- To determine optimal screening strategies based on expected quality-adjusted life years (QALYs).
Main Methods:
- Integration of a simulation model within a genetic algorithm for policy selection.
- Utilizing a probabilistic approach for identifying the most efficient screening policy.
- Comparison of algorithm-generated policies against previously recommended screening guidelines.
Main Results:
- The developed algorithm efficiently identifies optimal PSA screening policies.
- Computational results demonstrate the algorithm's effectiveness in policy design.
- The optimized policy suggests more aggressive but shorter screening durations compared to existing recommendations.
Conclusions:
- Simulation optimization provides a robust framework for PSA screening policy design.
- Evidence supports revising current guidelines towards more intensive, shorter screening intervals.
- The proposed method can lead to improved patient outcomes, measured by QALYs.
More Related Videos
06:08A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
Published on: March 21, 2025
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013